NB
GSK icon

NBT Bank’s GSK GSK Stock Holding History

NBT Bank’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$914K Buy
16,568
+315
+2% +$17.1K 0.06% 217
2025
Q4 		$797K Buy
16,253
+10
+0.1% +$466 0.05% 225
2025
Q3 		$701K Buy
16,243
+1,478
+10% +$57.7K 0.05% 238
2025
Q2 		$567K Buy
14,765
+452
+3% +$17.3K 0.04% 260
2025
Q1 		$554K Buy
14,313
+2,624
+22% +$96.1K 0.04% 259
2024
Q4 		$395K Sell
11,689
-789
-6% -$28.4K 0.03% 293
2024
Q3 		$510K Buy
12,478
+191
+2% +$7.81K 0.03% 277
2024
Q2 		$473K Buy
12,287
+209
+2% +$8.79K 0.03% 282
2024
Q1 		$518K Buy
12,078
+435
+4% +$17.9K 0.04% 267
2023
Q4 		$431K Buy
11,643
+3,180
+38% +$114K 0.03% 280
2023
Q3 		$307K Buy
8,463
+52
+0.6% +$1.85K 0.03% 264
2023
Q2 		$300K Buy
8,411
+394
+5% +$14.1K 0.04% 214
2023
Q1 		$285K Sell
8,017
-257
-3% -$8.99K 0.04% 218
2022
Q4 		$291K Buy
+8,274
New +$276K 0.04% 211
2022
Q3 		– Sell
-6,962
Closed -$379K – 231
2022
Q2 		$379K Buy
6,962
+68
+1% +$3.75K 0.06% 182
2022
Q1 		$376K Sell
6,894
-576
-8% -$31.3K 0.05% 184
2021
Q4 		$412K Sell
7,470
-560
-7% -$29.1K 0.05% 186
2021
Q3 		$383K Sell
8,030
-290
-3% -$14.6K 0.05% 183
2021
Q2 		$414K Sell
8,320
-104
-1% -$5K 0.06% 180
2021
Q1 		$376K Sell
8,424
-1,546
-16% -$70.2K 0.05% 182
2020
Q4 		$458K Hold
9,970
– – 0.07% 161
2020
Q3 		$470K Sell
9,970
-140
-1% -$7.01K 0.08% 157
2020
Q2 		$516K Hold
10,110
– – 0.09% 146
2020
Q1 		$478K Sell
10,110
-800
-7% -$42.7K 0.1% 143
2019
Q4 		$641K Hold
10,910
– – 0.1% 146
2019
Q3 		$582K Sell
10,910
-1,083
-9% -$55.7K 0.1% 149
2019
Q2 		$600K Sell
11,993
-80
-0.7% -$4.01K 0.11% 143
2019
Q1 		$631K Sell
12,073
-800
-6% -$40K 0.11% 137
2018
Q4 		$615K Sell
12,873
-1,433
-10% -$70.6K 0.1% 137
2018
Q3 		$718K Sell
14,306
-288
-2% -$14.6K 0.12% 133
2018
Q2 		$735K Sell
14,594
-290
-2% -$14.6K 0.13% 126
2018
Q1 		$727K Sell
14,884
-1,637
-10% -$76.2K 0.12% 133
2017
Q4 		$732K Sell
16,521
-401
-2% -$18.5K 0.12% 133
2017
Q3 		$859K Sell
16,922
-922
-5% -$46.8K 0.14% 131
2017
Q2 		$962K Sell
17,844
-1,654
-8% -$88.2K 0.16% 119
2017
Q1 		$1.03M Sell
19,498
-1,352
-6% -$68.6K 0.17% 114
2016
Q4 		$1M Sell
20,850
-747
-3% -$36.9K 0.17% 115
2016
Q3 		$1.16M Buy
21,597
+1,299
+6% +$71.2K 0.2% 109
2016
Q2 		$1.1M Buy
20,298
+1,076
+6% +$56.7K 0.19% 111
2016
Q1 		$975K Buy
19,222
+184
+1% +$9.16K 0.17% 114
2015
Q4 		$960K Sell
19,038
-316
-2% -$16.1K 0.17% 114
2015
Q3 		$930K Sell
19,354
-7,516
-28% -$391K 0.17% 114
2015
Q2 		$1.4M Sell
26,870
-352
-1% -$19.8K 0.23% 107
2015
Q1 		$1.57M Sell
27,222
-1,108
-4% -$63.5K 0.25% 103
2014
Q4 		$1.51M Buy
28,330
+456
+2% +$25.5K 0.24% 100
2014
Q3 		$1.6M Buy
27,874
+116
+0.4% +$7.11K 0.26% 100
2014
Q2 		$1.86M Sell
27,758
-488
-2% -$33K 0.28% 95
2014
Q1 		$1.89M Sell
28,246
-288
-1% -$19.5K 0.27% 97
2013
Q4 		$1.9M Sell
28,534
-2,799
-9% -$181K 0.27% 97
2013
Q3 		$1.97M Sell
31,333
-1,716
-5% -$110K 0.29% 93
2013
Q2 		$2.06M Buy
+33,049
New +$2.1M 0.31% 90

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

NBT Bank's GSK Position: Q1 2026 in Review

NBT Bank increased its GSK (GSK) stake by 1.9% in Q1 2026, buying an estimated $17.1K and bringing the position to 16,568 shares worth $914K. The position accounts for 0.06% of the portfolio, ranked #217.

NBT Bank first reported a position in GSK in Q2 2013 and has held it in 51 quarters since. The position peaked at $2.06M in Q2 2013. 1,032 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • NBT Bank held 16,568 shares of GSK worth $914K as of Q1 2026.
  • NBT Bank bought 315 GSK shares in Q1 2026, an estimated $17.1K.
  • GSK made up 0.06% of NBT Bank's portfolio in Q1 2026, its #217 holding.
  • NBT Bank first reported a position in GSK in Q2 2013 and has held it in 51 quarters since.
  • NBT Bank's GSK position peaked at $2.06M in Q2 2013.
  • 1,032 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on NBT Bank's 13F filing for Q1 2026, filed 28 Apr 2026.